Global Dermatology Drug Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Dermatology Drug Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.

According to APO Research, The global Dermatology Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Dermatology Drug include AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma and Valeant, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dermatology Drug, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Dermatology Drug, also provides the value of main regions and countries. Of the upcoming market potential for Dermatology Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dermatology Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Dermatology Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Dermatology Drug company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.

Dermatology Drug segment by Company

AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Dermatology Drug segment by Type

External Use
Oral
Injection
Dermatology Drug segment by Application

Psoriasis
Skin Infections
Acne
Dermatitis
Others
Dermatology Drug segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Dermatology Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Dermatology Drug key companies, revenue, market share, and recent developments.
3. To split the Dermatology Drug breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Dermatology Drug market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Dermatology Drug significant trends, drivers, influence factors in global and regions.
6. To analyze Dermatology Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dermatology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatology Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dermatology Drug industry.
Chapter 3: Detailed analysis of Dermatology Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Dermatology Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Dermatology Drug in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Dermatology Drug Market Size, 2019 VS 2023 VS 2030
1.3 Global Dermatology Drug Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Dermatology Drug Market Dynamics
2.1 Dermatology Drug Industry Trends
2.2 Dermatology Drug Industry Drivers
2.3 Dermatology Drug Industry Opportunities and Challenges
2.4 Dermatology Drug Industry Restraints
3 Dermatology Drug Market by Company
3.1 Global Dermatology Drug Company Revenue Ranking in 2023
3.2 Global Dermatology Drug Revenue by Company (2019-2024)
3.3 Global Dermatology Drug Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Dermatology Drug Company Manufacturing Base & Headquarters
3.5 Global Dermatology Drug Company, Product Type & Application
3.6 Global Dermatology Drug Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Dermatology Drug Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Dermatology Drug Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 Dermatology Drug Market by Type
4.1 Dermatology Drug Type Introduction
4.1.1 External Use
4.1.2 Oral
4.1.3 Injection
4.2 Global Dermatology Drug Sales Value by Type
4.2.1 Global Dermatology Drug Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Dermatology Drug Sales Value by Type (2019-2030)
4.2.3 Global Dermatology Drug Sales Value Share by Type (2019-2030)
5 Dermatology Drug Market by Application
5.1 Dermatology Drug Application Introduction
5.1.1 Psoriasis
5.1.2 Skin Infections
5.1.3 Acne
5.1.4 Dermatitis
5.1.5 Others
5.2 Global Dermatology Drug Sales Value by Application
5.2.1 Global Dermatology Drug Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Dermatology Drug Sales Value by Application (2019-2030)
5.2.3 Global Dermatology Drug Sales Value Share by Application (2019-2030)
6 Dermatology Drug Market by Region
6.1 Global Dermatology Drug Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Dermatology Drug Sales Value by Region (2019-2030)
6.2.1 Global Dermatology Drug Sales Value by Region: 2019-2024
6.2.2 Global Dermatology Drug Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Dermatology Drug Sales Value (2019-2030)
6.3.2 North America Dermatology Drug Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dermatology Drug Sales Value (2019-2030)
6.4.2 Europe Dermatology Drug Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Dermatology Drug Sales Value (2019-2030)
6.5.2 Asia-Pacific Dermatology Drug Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Dermatology Drug Sales Value (2019-2030)
6.6.2 Latin America Dermatology Drug Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Dermatology Drug Sales Value (2019-2030)
6.7.2 Middle East & Africa Dermatology Drug Sales Value Share by Country, 2023 VS 2030
7 Dermatology Drug Market by Country
7.1 Global Dermatology Drug Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Dermatology Drug Sales Value by Country (2019-2030)
7.2.1 Global Dermatology Drug Sales Value by Country (2019-2024)
7.2.2 Global Dermatology Drug Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.3.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.4.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.5.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.6.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.7.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.8.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.9.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.10.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.11.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.12.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.13.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.14.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.15.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.16.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.17.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.18.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.19.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.20.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.21.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 AbbVie
8.1.1 AbbVie Comapny Information
8.1.2 AbbVie Business Overview
8.1.3 AbbVie Dermatology Drug Revenue and Gross Margin (2019-2024)
8.1.4 AbbVie Dermatology Drug Product Portfolio
8.1.5 AbbVie Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Dermatology Drug Revenue and Gross Margin (2019-2024)
8.2.4 Johnson & Johnson Dermatology Drug Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Bayer
8.3.1 Bayer Comapny Information
8.3.2 Bayer Business Overview
8.3.3 Bayer Dermatology Drug Revenue and Gross Margin (2019-2024)
8.3.4 Bayer Dermatology Drug Product Portfolio
8.3.5 Bayer Recent Developments
8.4 Galderma
8.4.1 Galderma Comapny Information
8.4.2 Galderma Business Overview
8.4.3 Galderma Dermatology Drug Revenue and Gross Margin (2019-2024)
8.4.4 Galderma Dermatology Drug Product Portfolio
8.4.5 Galderma Recent Developments
8.5 Bristol-Myers Squibb
8.5.1 Bristol-Myers Squibb Comapny Information
8.5.2 Bristol-Myers Squibb Business Overview
8.5.3 Bristol-Myers Squibb Dermatology Drug Revenue and Gross Margin (2019-2024)
8.5.4 Bristol-Myers Squibb Dermatology Drug Product Portfolio
8.5.5 Bristol-Myers Squibb Recent Developments
8.6 Novartis
8.6.1 Novartis Comapny Information
8.6.2 Novartis Business Overview
8.6.3 Novartis Dermatology Drug Revenue and Gross Margin (2019-2024)
8.6.4 Novartis Dermatology Drug Product Portfolio
8.6.5 Novartis Recent Developments
8.7 Pfizer
8.7.1 Pfizer Comapny Information
8.7.2 Pfizer Business Overview
8.7.3 Pfizer Dermatology Drug Revenue and Gross Margin (2019-2024)
8.7.4 Pfizer Dermatology Drug Product Portfolio
8.7.5 Pfizer Recent Developments
8.8 Merz Pharma
8.8.1 Merz Pharma Comapny Information
8.8.2 Merz Pharma Business Overview
8.8.3 Merz Pharma Dermatology Drug Revenue and Gross Margin (2019-2024)
8.8.4 Merz Pharma Dermatology Drug Product Portfolio
8.8.5 Merz Pharma Recent Developments
8.9 Valeant
8.9.1 Valeant Comapny Information
8.9.2 Valeant Business Overview
8.9.3 Valeant Dermatology Drug Revenue and Gross Margin (2019-2024)
8.9.4 Valeant Dermatology Drug Product Portfolio
8.9.5 Valeant Recent Developments
8.10 LEO Pharma
8.10.1 LEO Pharma Comapny Information
8.10.2 LEO Pharma Business Overview
8.10.3 LEO Pharma Dermatology Drug Revenue and Gross Margin (2019-2024)
8.10.4 LEO Pharma Dermatology Drug Product Portfolio
8.10.5 LEO Pharma Recent Developments
8.11 GlaxoSmithKline
8.11.1 GlaxoSmithKline Comapny Information
8.11.2 GlaxoSmithKline Business Overview
8.11.3 GlaxoSmithKline Dermatology Drug Revenue and Gross Margin (2019-2024)
8.11.4 GlaxoSmithKline Dermatology Drug Product Portfolio
8.11.5 GlaxoSmithKline Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings